| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |